Review article: determination of the therapeutic range for therapeutic drug monitoring of adalimumab and infliximab in patients with inflammatory bowel disease
Author:
Affiliation:
1. Departments of Gastroenterology; The Alfred Hospital; Melbourne VIC Australia
2. Monash University; Melbourne VIC Australia
3. The Royal Melbourne Hospital; Melbourne VIC Australia
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15643/fullpdf
Reference94 articles.
1. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J med,2005
2. Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial;Sandborn;Gut,2007
3. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis;Ford;Am J Gastroenterol,2011
4. Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review;Billioud;Am J Gastroenterol,2011
5. Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review;Gisbert;Am J Gastroenterol,2009
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Infliximab Therapeutic monitoring by tryptic peptide LC-MS/MS method improvements lead to improved accuracy with decreased imprecision and turnaround time;Journal of Mass Spectrometry and Advances in the Clinical Lab;2024-02
2. Therapeutic drug monitoring of immunotherapies with novel Affimer–NanoBiT sensor construct;Sensors & Diagnostics;2024
3. Application of a Precision‐Dosing Model to a Real‐World Cohort of Patients on Infliximab Maintenance Therapy: Drug Usage and Cost Analysis;The Journal of Clinical Pharmacology;2023-12-03
4. Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn’s Disease: A Retrospective, International Multicenter Study;Inflammatory Bowel Diseases;2023-11-10
5. Synthesis and characterization of chitosan/polyvinylpyrrolidone hydrogels for controlled amoxicillin release;Journal of Bioactive and Compatible Polymers;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3